"lung cancer survivor" trang 9 - tải miễn phí từ tailieunhanh
The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer

The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer
9    87    0
Biology of MiR-17-92 cluster and its progress in lung cancer

Biology of MiR-17-92 cluster and its progress in lung cancer
6    56    0
Cinnamomum cassia extracts suppress human lung cancer cells invasion by reducing u-PA/MMP expression through the FAK to ERK pathways

Cinnamomum cassia extracts suppress human lung cancer cells invasion by reducing u-PA/MMP expression through the FAK to ERK pathways
9    120    0
The role of immune checkpoint inhibitor pembrolizumab in treatment of patients with non small cell lung cancer: Review

The role of immune checkpoint inhibitor pembrolizumab in treatment of patients with non small cell lung cancer: Review
7    78    1
Outcome and predicting chemotoxicity in elderly patients with advanced non-small cell lung cancer

Outcome and predicting chemotoxicity in elderly patients with advanced non-small cell lung cancer
5    88    0
Evaluating the efficiency of endobronchial ultrasound for diagnosis of patients with suspected lung cancer

Evaluating the efficiency of endobronchial ultrasound for diagnosis of patients with suspected lung cancer
9    96    0
Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis

Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis
12    60    0
RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma

RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma
18    85    0
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with nonsquamous non-small cell lung cancer in New Zealand

Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with nonsquamous non-small cell lung cancer in New Zealand
12    75    1
Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse

Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse
8    75    1
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: Therapeutic implications for immune checkpoint inhibitors

Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: Therapeutic implications for immune checkpoint inhibitors
10    40    1
A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage nonsmall cell lung cancer

A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage nonsmall cell lung cancer
10    82    1
Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): Study protocol for a randomized controlled trial

Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): Study protocol for a randomized controlled trial
10    52    1
The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma - differences in histological subtypes

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma - differences in histological subtypes
12    46    1
UBR-box containing protein, UBR5, is overexpressed in human lung adenocarcinoma and is a potential therapeutic target

UBR-box containing protein, UBR5, is overexpressed in human lung adenocarcinoma and is a potential therapeutic target
12    32    1
Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity

Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity
9    36    1
A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung

A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
4    50    1
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
5    36    1
Testing of human papillomavirus in lung cancer and non-tumor lung tissue

Testing of human papillomavirus in lung cancer and non-tumor lung tissue
3    42    1
The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial protocol

The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial protocol
9    60    1